PRP vs. Stem Cell Conditioned Media for the Knee: How Dr. Moriwaki Compares Autologous Blood and Cell-Derived Options as Knee Joint Injections2026.07.09

“I was recommended PRP for my knee pain, but I don’t really understand how it differs from stem cell conditioned media.” We hear this question more and more often from patients considering a knee joint injection for knee osteoarthritis. Both are frequently lumped together under “regenerative joint injection,” but their raw material, primary mechanism of action, and pharmaceutical character are meaningfully different. Choosing between them as a knee joint injection should be an integrated decision that considers disease stage, age, tolerance for blood draw, cost, and lifestyle. In this column, Dr. Moriwaki organizes the differences between PRP (Platelet-Rich Plasma) and stem cell conditioned media from three angles: mechanism, evidence, and clinical use.

Key Points of This Article

・PRP as a knee joint injection is an autologous product made from the patient’s own blood, driven mainly by platelet-derived growth factors.

・Stem cell conditioned media is a medium secreted by cultured stem cells, containing multiple cytokines, growth factors, and exosomes — a layered biological signal.

・PRP requires blood collection and a longer chair-time on the day, while stem cell conditioned media is a pre-manufactured product that does not require a blood draw.

・Neither is a “magic injection that directly regenerates cartilage.” It is more honest to position them as approaches that modulate the intra-articular inflammatory environment and repair response.

・Priority between the two knee joint injections shifts with the KL grade, the amount of knee effusion, and the patient’s treatment history.

PRP and Stem Cell Conditioned Media Differ in Both “Origin” and “Action” as Knee Joint Injections

PRP Is an Autologous Product Made from Your Own Blood

PRP stands for Platelet-Rich Plasma. Blood is drawn from the patient, centrifuged, and the platelet-concentrated fraction is returned into the knee joint cavity. Platelets store multiple growth factors — PDGF (platelet-derived growth factor), TGF-β, VEGF, EGF — in α-granules and release them into the joint upon activation. Because it is autologous, immunological rejection risk is very low.

Stem Cell Conditioned Media Is the Secretome, Not the Cells

Stem cell conditioned media, by contrast, is the liquid fraction collected during in-vitro culture of mesenchymal stem cells (from adipose, umbilical cord, dental pulp, etc.). It contains the growth factors, cytokines, exosomes, and miRNAs that the cells secreted into the culture medium — but not the cells themselves. Because we use only the “footprint of cellular activity” as a knee joint injection, this is fundamentally a different concept from cell transplantation.

How the Mechanism and Growth Factor Profile Differ as Knee Joint Injections

PRP Delivers Platelet-Derived Growth Factors

What is injected in PRP is the growth-factor pool stored in α-granules. Composition depends heavily on the patient’s blood condition on that day — CBC, inflammation state, and nutritional status. How platelet-derived signals act on cartilage matrix metabolism and the synovial inflammatory cycle is actively researched, but for halting osteoarthritis progression, long-term outcomes still show meaningful limitations and individual variability.

Stem Cell Conditioned Media Delivers Multi-Layered Intercellular Signals

A knee joint injection with stem cell conditioned media contains not only platelet-derived growth factors but a diverse profile of cytokines — IGF-1, HGF, FGF, TGF-β, SDF-1 — and extracellular vesicles called exosomes. Exosomes carry miRNAs and other gene-regulatory molecules, and basic research has reported potential involvement in suppressing synovitis and improving the metabolic environment for chondrocytes. However, there is no established clinical evidence that lets us claim “cartilage itself is restored to its original state.” We position it as a biological approach that modulates the intra-articular inflammatory environment and repair response.

Blood Draw Burden, Lot Standardization, and Cost Differences

PRP requires a blood draw on the day of treatment. Depending on the protocol, several tens of mL of blood are collected, and the in-clinic time until injection is typically around one hour due to centrifugation. Patients on anticoagulants or antiplatelet drugs, or those with significant anemia, may require careful assessment of the blood draw itself. Stem cell conditioned media, on the other hand, is a pre-manufactured frozen product that is thawed before use, so no blood draw is required, and chair-time is limited to the injection procedure itself. In terms of lot standardization, PRP is an “individual batch made from the patient’s blood that day,” while stem cell conditioned media is a product where “the same lot is used across multiple patients,” allowing component and sterility testing to be confirmed via a Certificate of Analysis (CoA).

At Which Stage of Knee Osteoarthritis Should Each Knee Joint Injection Be Considered

Selecting a knee joint injection is an integrated decision — KL grade, presence of joint effusion, prior response to hyaluronic acid or steroid injections, age, activity level, and life circumstances such as work or caregiving. For general information on joint disease, please also refer to the Japanese Orthopaedic Association website. At our clinic, we perform X-ray, MRI if needed, range-of-motion, and gait assessments at the first visit. After first establishing a foundation of conservative care (exercise therapy, bracing, lifestyle guidance), we discuss whether PRP or stem cell conditioned media would be the more appropriate knee joint injection. In cases of severely destroyed joints (KL grade IV), active infection, or uncontrolled systemic disease, either knee joint injection may be contraindicated or require careful judgment. Rather than seeking a “one-shot fix” with a knee joint injection, we believe regenerative medicine finds its proper place when combined with exercise therapy, bracing, and weight management to gradually rebuild pain and function. Please also see our detailed page on joint injection with stem cell conditioned media.

Frequently Asked Questions

Q. Can PRP and stem cell conditioned media be used together on the same day?

There is no explicit rule prohibiting combined use, but injecting multiple biological products into the knee joint cavity on the same day makes it difficult to judge which is producing the effect, and from a cost-effectiveness standpoint we do not actively recommend it. Staggering timing for evaluation is clinically more rational.

Q. Which knee joint injection is more effective?

We cannot make a blanket judgment. PRP offers the reassurance of autologous origin and a relatively simple platelet-derived growth-factor action. Stem cell conditioned media offers a diverse cytokine and exosome profile but relies on lot quality confirmation and informed consent. The choice should be based on indication, disease stage, and lifestyle.

Q. How many sessions until I feel an effect?

Individual variation is significant. Generally, the course is evaluated over weeks to months, and the number of sessions is designed while objectively tracking pain scores, range of motion, and activities of daily living. The knee joint injection alone is not intended to “cure” — a comprehensive plan combined with rehabilitation is essential.

Q. How does this differ from hyaluronic acid injection?

Hyaluronic acid physically supplements joint lubrication and viscoelasticity. PRP and stem cell conditioned media are biological approaches that modulate the intra-articular inflammatory environment and repair response via growth factors and cytokines — they target different layers with different goals.

Q. What kind of side effects should I expect?

All knee joint injections carry risks associated with the procedure itself — bruising, transient swelling or pain, and very rare infection. Careful assessment is especially needed for patients with significant knee effusion or poorly controlled diabetes.

──────────────

Supervising Physician: Shin Moriwaki, MD

Member, Japan Society of Aesthetic Surgery (JSAS) / Member, American Academy of Aesthetic Medicine

ECFMG certificate holder

──────────────

📍AVAN TOKYO Ginza Regenerative Medicine

AVAN TOKYO Ginza Regenerative Medicine

English / 中文 / Tiếng Việt supported

Inquiries welcome via DM / LINE / Website / Phone.